Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 2
2019 3
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
The Future of Regenerative Medicine: Cell Therapy Using Pluripotent Stem Cells and Acellular Therapies Based on Extracellular Vesicles.
Jarrige M, Frank E, Herardot E, Martineau S, Darle A, Benabides M, Domingues S, Chose O, Habeler W, Lorant J, Baldeschi C, Martinat C, Monville C, Morizur L, Ben M'Barek K. Jarrige M, et al. Among authors: lorant j. Cells. 2021 Jan 27;10(2):240. doi: 10.3390/cells10020240. Cells. 2021. PMID: 33513719 Free PMC article. Review.
Human MuStem cells repress T-cell proliferation and cytotoxicity through both paracrine and contact-dependent pathways.
Charrier M, Lorant J, Contreras-Lopez R, Téjédor G, Blanquart C, Lieubeau B, Schleder C, Leroux I, Deshayes S, Fonteneau JF, Babarit C, Hamel A, Magot A, Péréon Y, Viau S, Delorme B, Luz-Crawford P, Lamirault G, Djouad F, Rouger K. Charrier M, et al. Among authors: lorant j. Stem Cell Res Ther. 2022 Jan 10;13(1):7. doi: 10.1186/s13287-021-02681-3. Stem Cell Res Ther. 2022. PMID: 35012660 Free PMC article.
Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle.
Lorant J, Saury C, Schleder C, Robriquet F, Lieubeau B, Négroni E, Leroux I, Chabrand L, Viau S, Babarit C, Ledevin M, Dubreil L, Hamel A, Magot A, Thorin C, Guevel L, Delorme B, Péréon Y, Butler-Browne G, Mouly V, Rouger K. Lorant J, et al. Mol Ther. 2018 Feb 7;26(2):618-633. doi: 10.1016/j.ymthe.2017.10.013. Epub 2017 Oct 20. Mol Ther. 2018. PMID: 29221805 Free PMC article.
Vascular Delivery of Allogeneic MuStem Cells in Dystrophic Dogs Requires Only Short-Term Immunosuppression to Avoid Host Immunity and Generate Clinical/Tissue Benefits.
Lorant J, Larcher T, Jaulin N, Hedan B, Lardenois A, Leroux I, Dubreil L, Ledevin M, Goubin H, Moullec S, Deschamps JY, Thorin C, André C, Adjali O, Rouger K. Lorant J, et al. Cell Transplant. 2018 Jul;27(7):1096-1110. doi: 10.1177/0963689718776306. Epub 2018 Jun 5. Cell Transplant. 2018. PMID: 29871519 Free PMC article.
CICAFAST: comparison of a biological dressing composed of fetal fibroblasts and keratinocytes on a split-thickness skin graft donor site versus a traditional dressing: a randomized controlled trial.
Poinas A, Perrot P, Lorant J, Nerrière O, Nguyen JM, Saiagh S, Frenard C, Leduc A, Malard O, Espitalier F, Duteille F, Chiffoleau A, Vrignaud F, Khammari A, Dréno B. Poinas A, et al. Among authors: lorant j. Trials. 2019 Oct 28;20(1):612. doi: 10.1186/s13063-019-3718-4. Trials. 2019. PMID: 31661012 Free PMC article. Clinical Trial.